Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial

William J. Stone(Radboud University Nijmegen), Alassane Dicko(University of Bamako), Halimatou Diawara(Unknown), Teun Bousema(Radboud University Nijmegen), Chris Drakeley(London School of Hygiene & Tropical Medicine), Djibrilla Issiaka, Harouna M Soumaré(Centre National de la Recherche Scientifique), Makonon Diallo, Kjerstin Lanke(Radboud University Medical Center), John Bradley(London School of Hygiene & Tropical Medicine), Sidi M. Niambele, Harparkash Kaur(London School of Hygiene & Tropical Medicine), Almahamoudou Mahamar(University of Bamako), Sekouba Keita, Sékou F. Traorè, Adama Sacko, Rob ter Heine(Radboud University Nijmegen), Koualy Sanogo, Youssouf Sinaba
The Lancet Microbe
October 22, 2021
Cited by 38


Related Papers